BARBARA VARGA: Open Payments
NPI 1982039822 · GREENVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,473 in 119 payments from 23 companies in 2025. Trend: 2023 $2,801 · 2024 $2,446 · 2025 $2,473
Food & beverage: $2,378Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $431 |
| ABBVIE INC. | 5 | $306 |
| GlaxoSmithKline, LLC. | 17 | $236 |
| GENZYME CORPORATION | 13 | $199 |
| Regeneron Healthcare Solutions, Inc. | 11 | $186 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $151 |
| CSL Behring | 9 | $137 |
| Novo Nordisk Inc | 2 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, QULIPTA, NEFFY, FASENRA, Ozempic, VRAYLAR.
Industry payments across PA — which companies pay providers there.
